Skip to main content
v2026.11,772 entries · CC-BY 4.0
Dictionary termTrack DStablev2026.2

Withdrawal of consent

The exercise by a research participant of the right to revoke their consent to ongoing participation in research, after which the investigator must cease prospective collection of data or biospecimens from that participant and apply the protocol-specified handling of data already collected.

ByCASRAI Editorial Board
· Last updated 22 Aug 2026
Share this

Ask CASRAI · included with Regulatory Radar

Ask about Withdrawal of consent

Ask CASRAI answers research-administration questions and cites the passages behind every claim — and says so when the corpus does not cover something, instead of guessing. It comes with a Regulatory Radar subscription at $29 a month, alongside the daily digest of regulatory changes and the dashboard of what changed.

150 questions a day, on this site, over the API, or inside your own tools through the CASRAI MCP server.

Everything CASRAI publishes — this page, the dictionary, the guides and the news — stays free to read, with no account and no card.

Examples

Worked examples

  • Is an instance

    A trial participant notifies the coordinator that they wish to withdraw; the site stops further visits and follows the protocol's pre-specified plan to retain anonymised data already collected.

  • Is an instance

    A biobank participant uses the dynamic-consent portal to withdraw consent for future use of stored specimens; the biobank flags the sample identifier so no further releases occur.

Counter-examples

Looks similar, but isn't

  • Not an instance

    A participant declining a single study visit while remaining enrolled is not a withdrawal of consent.

  • Not an instance

    Loss to follow-up where the participant cannot be contacted is not a withdrawal and does not by itself trigger destruction of collected data.

Editorial commentary

Withdrawal is a fundamental right under all major human-subjects frameworks and must be available without penalty or loss of benefits. Protocols should specify at consent whether previously collected data and samples will be destroyed, retained in identifiable form, or retained in coded/anonymised form on withdrawal, and the consent form must accurately describe these choices. Under the GDPR, withdrawal of consent under Article 7(3) does not by itself require deletion of data already lawfully processed for research purposes where another lawful basis or a research-purposes safeguard under Article 89 applies, but the institution must clearly explain this distinction in the consent process.

Two different things “withdrawal” can mean

Research administrators and IRBs distinguish withdrawal from further participation (the subject stops undergoing study procedures or providing new data going forward) from withdrawal of already-collected identifiable data or specimens (the subject asks for what has already been collected to be removed or destroyed). The first is always available and must involve no penalty. The second is often only partially achievable: once data has been de-identified, aggregated, analysed, or already incorporated into a locked dataset or a publication, it may not be practicable — or, once results are published, even meaningful — to retroactively remove it. A well-written consent form sets this expectation up front rather than implying an unqualified right to have already-used data erased.

What a protocol must specify at consent

Because the two forms of withdrawal have different practical limits, the consent process should specify, before data collection begins, what will happen to already-collected material on withdrawal: whether it will be destroyed, retained in identifiable form with the subject’s permission, or retained only in coded/de-identified form. This is a required element of an adequate consent process under the Common Rule’s general 46.116 disclosure standard, not a separate optional add-on.

ICH GCP and clinical trial withdrawal

ICH GCP (E6) treats participant withdrawal in a clinical trial as always permissible without justification or penalty, but distinguishes it from investigator-initiated discontinuation (removing a participant for safety, non-compliance, or protocol reasons) — the two are recorded and reported differently, and a sponsor’s safety and efficacy analyses must account for withdrawals consistently with the trial’s pre-specified statistical analysis plan rather than simply dropping withdrawn participants’ existing data from an ongoing safety assessment.

References

  • Common Rule 45 CFR §46.116(b)(8) statement of right to withdraw
  • GDPR Regulation (EU) 2016/679 Article 7(3) withdrawal of consent
  • ICH GCP E6(R3) Guideline (2023), provisions on withdrawal of trial participants

Related: Informed consent · Broad consent · Dynamic consent · Common Rule (45 CFR 46).

Also known as

consent withdrawal · revocation of consent · withdrawal from research

Machine-readable encodings

Use in your systems

JATS XML <role> element
xml
<role vocab="credit"
      vocab-identifier="https://casrai.org/dictionary/"
      vocab-term="Withdrawal of consent"
      vocab-term-identifier="https://casrai.org/dictionary/term/withdrawal-of-consent" />
Schema.org DefinedTerm (JSON-LD)
json
{
  "@context": "https://schema.org",
  "@type": "DefinedTerm",
  "@id": "https://casrai.org/dictionary/term/withdrawal-of-consent",
  "name": "Withdrawal of consent",
  "identifier": "https://casrai.org/dictionary/term/withdrawal-of-consent",
  "description": "The exercise by a research participant of the right to revoke their consent to ongoing participation in research, after which the investigator must cease prospective collection of data or biospecimens from that participant and apply the protocol-specified handling of data already collected.",
  "inDefinedTermSet": "https://casrai.org/dictionary/domain/compliance-regulatory#set",
  "url": "https://casrai.org/dictionary/term/withdrawal-of-consent",
  "sameAs": [
    "consent withdrawal",
    "revocation of consent",
    "withdrawal from research"
  ],
  "license": "https://creativecommons.org/licenses/by/4.0/",
  "publisher": {
    "@id": "https://casrai.org/#organization"
  },
  "author": {
    "@id": "https://casrai.org/#editorial-team"
  },
  "datePublished": "2026-05-21T02:22:53",
  "dateModified": "2026-08-22T12:18:09",
  "inLanguage": "en-GB",
  "isAccessibleForFree": true
}

Referenced across the research world

University of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logoUniversity of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logo
  • University of Cambridge logo
  • Columbia University logo
  • Crossref logo
  • University of Edinburgh logo
  • Harvard University logo
  • University of Oxford logo
  • Princeton University logo
  • Stanford School of Medicine logo
  • University College London logo
  • ORCID logo

View CASRAI adoption →

Regulatory Radar

Stop finding out after the fact

$29/month, cancel anytime. Daily digest updates from our analysis, a dashboard holding the same items, and a cited assistant for everything they raise.

  • Federal Register, Federal Register+, Grants.gov, Regulations.gov, NSF News, UKRI, plus CASRAI’s own published content.
  • 72,264 indexed passages, and every answer cites the ones it drew on.